Zebra Tech

ZBRA declined 1.54% to $245.48 today, primarily reflecting profit-taking momentum following its recent strong performance. However, the company's latest quarterly results demonstrate sustained operational strength, with Q1 revenue reaching $1.495 billion, up 14.3% year-over-year, and EPS of $2.72, up 3.82% year-over-year, accompanied by a significant sequential improvement in net profit margin to 9.03%. These results have prompted multiple analysts, including BNP Paribas Exane, to raise price targets to $267, underscoring confidence in operational trajectory. The launch of new DNA software platforms and AI-powered frontline worker solutions represents an emerging growth catalyst. From a valuation perspective, the stock stands 30.39% below its 52-week high of $352.66, yet above its 60-day moving average of $226.84, with year-to-date performance showing a modest 1.14% decline against a market capitalization of approximately $11.69 billion. However, the current PE ratio of 27.97 indicates elevated valuation multiples that may constrain near-term upside potential.